hotspot -WSS

hotspot

author：fashion 2025-10-01 22:59:59 - browse：9759

Vertex Pharmaceuticals - sunset — Bill Sikes/AP

Vertex Pharmaceuticals has spent decades trying to develop molecules that reduce pain safely and potently, searching for success in a field its own executives have dubbed a graveyard for drug discovery. Detailed data published Wednesday lent support to that quest, with a pair of company-sponsored clinical trials showing an experimental non-opioid therapy reduced pain after surgery.

The drug, VX-548, blocks signals from pain-sensitive neurons before those electrical messages reach the brain. And in a pair of randomized trials, patients given a high dose of the oral medication after bunion surgery or abdominoplasty (a tummy tuck) reported less pain than those given a placebo. Those taking lower doses of the treatment showed no improvement compared to the placebo group, however.

While the pain reduction measured by these Phase 2 trials was statistically significant, it’s unclear how meaningful the drug’s benefits were to patients, with a commentary accompanying the study describing the treatment effect as “small.” But the study authors noted that participants on a high dose of VX-548 were less likely to prematurely stop their treatment because it wasn’t working than those on placebo or participants given a combination of two common painkillers, acetaminophen and hydrocodone.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

WSS

With FDA staff opposed to Sarepta therapy, top official intervened

New guidelines on severe brain injury complicate already difficult decisions

New guidelines on severe brain injury complicate already difficult decisions

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Why drug prescriptions should include diagnoses

New guidelines on severe brain injury complicate already difficult decisions

hotspot

hotspot

Wikipedia

What does generative AI mean for health care? We asked experts

The battle over the Brookhaven Landfill on Long Island

At least 13 dead in Texas as scorching temps continue

Vir antibody drug aimed at influenza A fails in clinical trial

Medicare proposal to cover medical devices draws a mixed reaction

Stanford president's case begs question: Who takes blame?

Anesthesiologist group: stop taking Ozempic before surgery

Why are elite athletes different? Take a look at their microbes

United colonoscopy coverage change 'may cost lives,' doctors say

The story of mRNA: From a loose idea to a tool that may help curb Covid

focus

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

Tocagen's brain cancer gene therapy trial continues. Investors worry

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Driven by the pandemic, applicants flood public health schools

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Why we need to separate burnout from moral injury in health care

explore

leisure time

hotspot

knowledge